Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Xavier Masramón"'
Publikováno v:
Clinical Drug Investigation. 32:401-412
Background: It has been suggested that peripheral neuropathic pain (PNP) may affect up to 3% of the general population. PNP has a substantial negative impact on patient functioning and quality of life, including reduced productivity and increased con
Publikováno v:
Pain Practice. 12:382-393
Purpose: To analyze the changes in pain severity and associated costs resulting from resource utilization and reduced productivity in patients with gabapentin-refractory peripheral neuropathic pain who switched to pregabalin therapy in primary care s
Autor:
Virginia Morillo, Ana Mañas, María Luisa Gonzálvez, Xavier Masramón, V. López-Gómez, Juan Pablo Ciria, María Carmen Fernández, Maria Pérez
Publikováno v:
Clinical and Translational Oncology. 13:656-663
A previous study of cancer-related neuropathic pain (NP) found that a 10-fold increase in pregabalin (PGB) use increased patients' satisfaction with treatment. Further research of PGB vs. non-pregabalin (non-PGB) treatment was carried out to assess i
Autor:
Xavier Masramón, Félix Ceberio-Balda, María Pérez, Carles Morera-Domínguez, Mariano Flórez-García
Publikováno v:
Pain Practice. 11:369-380
Background: The study aims to prospectively analyze the effect of adding pregabalin upon costs and consequences in the treatment of refractory neck pain under routine medical practice. Methods: A secondary analysis was carried out including patients
Autor:
Vicente Iváñez, María Pérez, Jerónimo Sancho, Albert Molins, Xavier Masramón, Vanessa López Gómez
Publikováno v:
Epilepsy & Behavior. 19:409-413
This 6-month observational, prospective, multicenter study assessed the influence of changes in seizure severity on quality of life in patients with refractory partial epilepsy. Patients (N = 262) diagnosed with partial epilepsy and receiving two ant
Publikováno v:
Clinical Therapeutics. 32:1357-1370
Background: Pregabalin and gabapentin are marketed to treat peripheral neuropathic pain, but head-to-head comparison is lacking. Objectives: The aims of this work were to compare the effects of pregabalin and gabapentin on different patient-reported
Publikováno v:
Rheumatology International
The objective of this study was to evaluate the effect of pregabalin in painful cervical or lumbosacral radiculopathy treated in Primary Care settings under routine clinical practice. An observational, prospective 12-week secondary analysis was carri
Autor:
Juan Cosín Aguilar, Amparo Hernándiz Martínez, Luis Rodríguez Padial, Xavier Masramón Morell, Beatriz Armada Peláez, Rosa Arístegui Urrestarazu, Amparo Aguilar Llopis, José Luis Zamorano Gómez
Publikováno v:
Medicina Clínica. 129:641-645
Fundamento y objetivo La obesidad es un factor de riesgo mayor e independiente para enfermedad cardiovascular. Hemos estudiado la distribucion del sobrepeso y la obesidad en una muestra de pacientes hipertensos de Espana (estudio CORONARIA), los fact
Autor:
Jose L. Zamorano-Gómez, Luis Rodríguez-Padial, Xavier Masramón-Morell, Rosa Arístegui-Urrestarazu, Amparo Aguilar-Llopis, Juan Cosín-Aguilar, Amparo Hernandiz-Martinez
Publikováno v:
Revista Española de Cardiología. 59:1026-1032
Introduccion y objetivos La afectacion renal supone un cambio importante en la evolucion de la enfermedad cardiovascular del hipertenso, pero la frecuencia con que las manifestaciones renales se estudian en el paciente ambulatorio es muy escasa. Se h
Autor:
Beatriz Armada Peláez, Amparo Aguilar Llopis, Juan Cosín Aguilar, Amparo Hernándiz Martínez, Xavier Masramón Morell, José Luis Zamorano Gómez, Luis Rodríguez Padial, Rosa Arístegui Urrestarazu
Publikováno v:
Medicina Clínica. 127:126-132
Fundamento y objetivo La diabetes mellitus es una enfermedad con una elevada prevalencia y mortalidad cardiovasculares. En el estudio CORONARIA se incluyeron datos de 7.253 pacientes con hipertension arterial y otro factor de riesgo de las 17 comunid